A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies

Area of Science:

• Immunology
• Biomarker Discovery
• Clinical Trials

Background:

• Standardized flow cytometry protocols are crucial for reproducible biomarker analysis in clinical studies.
• Current methods lack standardization, limiting multi-center validation and data comparability.
• Hematopoietic stem cell transplantation (HSCT) patient immune monitoring requires robust phenotyping.

Purpose of the Study:

• To develop and validate a standardized flow cytometry platform for multi-center clinical studies.
• To ensure high reproducibility and inter-center comparability of immune cell profiling.
• To establish automated analysis pipelines for efficient and accurate data processing.

Main Methods:

• Development of a standardized platform with pre-formatted antibody cocktails and acquisition protocols.
• Testing reproducibility across multiple centers using unfractionated blood and cryopreserved peripheral blood mononuclear cells (PBMCs).
• Validation of automated gating pipelines against manual analysis on independent datasets.

Main Results:

• The platform demonstrated high reproducibility and low inter-center variation (<20% CV, ICC >0.75) for most immune cell populations.
• Low-abundance or cryopreservation-sensitive populations (e.g., plasmablasts, CD62L+ cells) showed higher variability.
• Automated gating pipelines achieved high correlation (rs >0.9) with manual gating, confirming accuracy.

Conclusions:

• The developed platform provides a standardized, reproducible workflow for immune phenotyping in multicenter clinical trials.
• This approach enhances the reliability of biomarker analysis and facilitates data comparison across studies.
• Implementation of this platform can significantly improve the quality and consistency of immunological data in clinical research.